GlaxoSmithKline’s CEO Emma Walmsley has ... issued with Celgene’s shares mean that profitability is hinged on the success of pipeline drugs ozanimod, liso-cel and bb2121.

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price ...

In a report released today, Jo Walton from UBS maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...

The creation of GlaxoSmithKline, forged out of the merger of Glaxo Wellcome ... He talks passionately about the new structure he has pinned his success on. 'At Smith-Kline and Glaxo, we had two very ...

GlaxoSmithKline (GSK) has agreed to acquire Chimagen Biosciences’ CMG1A46, a clinical-stage therapy designed to target B cell ...

After a quarter century as a serial entrepreneur, Eric Lefkofsky wants his latest unicorn, health tech firm Tempus AI, to be the “enduring legacy” of his career. Here’s how he hopes it will ...

This is dangerous on multiple levels and AI Washing, as it is called, is already endemic across the business landscape. For ...

The FDA has approved use of GlaxoSmithKline’s Boostrix (Tdap ... Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically ...

After decades as a political outsider, Sanders has used his committee chairmanships and proximity to the White House to ...

The presence of M-AAT protein was used as confirmation of successful editing of mutant ... Wave’s up-to-$3.3 billion collaboration with GlaxoSmithKline (GSK), launched in December 2022.

A little over six months into her appointment, Chimeric’s youthful chief operating officer – and in effect CEO – Dr Rebecca ...

The curriculum offers focus and flexibility, allowing students to define their path to success. Graduate students are vigorously ... op positions with a variety of industry leaders, such as ...